| 1 |
Zhang L, Hou S, Movahedi F, Li Z, Li L, Hu J, Jia Y, Huang Y, Zhu J, Sun X, Zeng L, Liu R, Xu ZP. Amyloid-β/Tau burden and neuroinflammation dual-targeted nanomedicines synergistically restore memory and recognition of Alzheimer’s disease mice. Nano Today 2023;49:101788. [DOI: 10.1016/j.nantod.2023.101788] [Reference Citation Analysis]
|
| 2 |
Wang Y, Wang K, Luo Y, Chen H. Hydrogel-Bondable Asymmetric Planar Membranes with Hierarchical Pore Structures for Cell Scaffolding and Encapsulation. ACS Biomater Sci Eng 2023;9:1706-19. [PMID: 36795620 DOI: 10.1021/acsbiomaterials.2c01415] [Reference Citation Analysis]
|
| 3 |
Shu Y, Ma M, Pan X, Shafiq M, Yu H, Chen H. Cobalt protoporphyrin-induced nano-self-assembly for CT imaging, magnetic-guidance, and antioxidative protection of stem cells in pulmonary fibrosis treatment. Bioactive Materials 2023;21:129-141. [DOI: 10.1016/j.bioactmat.2022.08.008] [Reference Citation Analysis]
|
| 4 |
Yu J, Jiang G, Wang J. In Vivo Fluorescence Imaging-Guided Development of Near-Infrared AIEgens. Chem Asian J 2023;18:e202201251. [PMID: 36637344 DOI: 10.1002/asia.202201251] [Reference Citation Analysis]
|
| 5 |
Wei M, Yang Z, Li S, Le W. Nanotherapeutic and Stem Cell Therapeutic Strategies in Neurodegenerative Diseases: A Promising Therapeutic Approach. Int J Nanomedicine 2023;18:611-26. [PMID: 36760756 DOI: 10.2147/IJN.S395010] [Reference Citation Analysis]
|
| 6 |
Yao W, Che J, Zhao C, Zhang X, Zhou H, Bai F. Treatment of Alzheimer's disease by microcapsule regulates neurotransmitter release via microfluidic technology. Engineered Regeneration 2023. [DOI: 10.1016/j.engreg.2023.02.005] [Reference Citation Analysis]
|
| 7 |
Zhou Z, Shi B, Xu Y, Zhang J, Liu X, Zhou X, Feng B, Ma J, Cui H. Neural stem/progenitor cell therapy for Alzheimer disease in preclinical rodent models: a systematic review and meta-analysis. Stem Cell Res Ther 2023;14:3. [PMID: 36600321 DOI: 10.1186/s13287-022-03231-1] [Reference Citation Analysis]
|
| 8 |
Duan Y, Lyu L, Zhan S. Stem Cell Therapy for Alzheimer's Disease: A Scoping Review for 2017-2022. Biomedicines 2023;11. [PMID: 36672626 DOI: 10.3390/biomedicines11010120] [Reference Citation Analysis]
|
| 9 |
Aerqin Q, Wang ZT, Wu KM, He XY, Dong Q, Yu JT. Omics-based biomarkers discovery for Alzheimer's disease. Cell Mol Life Sci 2022;79:585. [PMID: 36348101 DOI: 10.1007/s00018-022-04614-6] [Reference Citation Analysis]
|
| 10 |
Xu J, Zhang Y, Liu Y, You Y, Li F, Chen Y, Xie L, Tong S, Zhou S, Liang K, Huang Y, Jiang G, Song Q, Mei N, Ma F, Gao X, Wang H, Chen J. Vitality-Enhanced Dual-Modal Tracking System Reveals the Dynamic Fate of Mesenchymal Stem Cells for Stroke Therapy. Small 2022;18:e2203431. [PMID: 36180405 DOI: 10.1002/smll.202203431] [Reference Citation Analysis]
|
| 11 |
Zhao S, Zhang Q, Liu M, Du J, Wang T, Li Y, Zeng W. Application of stem cells in engineered vascular graft and vascularized organs. Seminars in Cell & Developmental Biology 2022. [DOI: 10.1016/j.semcdb.2022.10.003] [Reference Citation Analysis]
|
| 12 |
Shi B, Zhao J, Xu Z, Chen C, Xu L, Xu C, Sun M, Kuang H. Chiral Nanoparticles Force Neural Stem Cell Differentiation to Alleviate Alzheimer's Disease. Adv Sci (Weinh) 2022;:e2202475. [PMID: 36008133 DOI: 10.1002/advs.202202475] [Reference Citation Analysis]
|
| 13 |
Zhang M, Fu H, Hu W, Leng J, Zhang Y. Versatile Dicyanomethylene-Based Fluorescent Probes for the Detection of β-Amyloid in Alzheimer’s Disease: A Theoretical Perspective. IJMS 2022;23:8619. [DOI: 10.3390/ijms23158619] [Reference Citation Analysis]
|
| 14 |
Luo M, Lee LKC, Peng B, Choi CHJ, Tong WY, Voelcker NH. Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases. Advanced Science. [DOI: 10.1002/advs.202201740] [Reference Citation Analysis]
|
| 15 |
Yu D, Zhang H, Liu Z, Liu C, Du X, Ren J, Qu X. Hydrogen‐Bonded Organic Framework (HOF)‐Based Single‐Neural Stem Cell Encapsulation and Transplantation to Remodel Impaired Neural Networks. Angew Chem Int Ed 2022;61. [DOI: 10.1002/anie.202201485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Xu Z, Qu A, Zhang H, Wang W, Hao C, Lu M, Shi B, Xu L, Sun M, Xu C, Kuang H. Photoinduced elimination of senescent microglia cells in vivo by chiral gold nanoparticles. Chem Sci 2022;13:6642-54. [PMID: 35756519 DOI: 10.1039/d2sc01662a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Yuan Q, Bao B, Li M, Tang Y. Bioactive Composite Nanoparticles for Effective Microenvironment Regulation, Neuroprotection, and Cell Differentiation. ACS Appl Mater Interfaces 2022;14:15623-31. [PMID: 35322659 DOI: 10.1021/acsami.2c00579] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 18 |
Xi Y, Chen Y, Jin Y, Han G, Song M, Song T, Shi Y, Tao L, Huang Z, Zhou J, Ding Y, Zhang H. Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Ma R, Zhao L, Zhao Y, Li Y. Puerarin action on stem cell proliferation, differentiation and apoptosis: Therapeutic implications for geriatric diseases. Phytomedicine 2022;96:153915. [PMID: 35026503 DOI: 10.1016/j.phymed.2021.153915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Geng H, Gao D, Wang Z, Liu X, Cao Z, Xing C. Strategies for Inhibition and Disaggregation of Amyloid‐β Fibrillation. Chin J Chem 2022;40:524-38. [DOI: 10.1002/cjoc.202100646] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 21 |
Jeong H, Kim OJ, Oh SH, Lee S, Reum Lee HA, Lee KO, Lee BY, Kim NK. Extracellular Vesicles Released from Neprilysin Gene-Modified Human Umbilical Cord-Derived Mesenchymal Stem Cell Enhance Therapeutic Effects in an Alzheimer's Disease Animal Model. Stem Cells Int 2021;2021:5548630. [PMID: 34899919 DOI: 10.1155/2021/5548630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 22 |
Yan C, Wang C, Shao X, Shu Q, Hu X, Guan P, Teng Y, Cheng Y. Dual-targeted carbon-dot-drugs nanoassemblies for modulating Alzheimer's related amyloid-β aggregation and inhibiting fungal infection. Mater Today Bio 2021;12:100167. [PMID: 34901820 DOI: 10.1016/j.mtbio.2021.100167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 23 |
Xu Z, Qu A, Wang W, Lu M, Shi B, Chen C, Hao C, Xu L, Sun M, Xu C, Kuang H. Facet-Dependent Biodegradable Mn3 O4 Nanoparticles for Ameliorating Parkinson's Disease. Adv Healthc Mater 2021;10:e2101316. [PMID: 34601811 DOI: 10.1002/adhm.202101316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 24 |
Zhou X, Hu S, Wang S, Pang Y, Lin Y, Li M. Large Amino Acid Mimicking Selenium-Doped Carbon Quantum Dots for Multi-Target Therapy of Alzheimer's Disease. Front Pharmacol 2021;12:778613. [PMID: 34776988 DOI: 10.3389/fphar.2021.778613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 25 |
Arora S, Sharma D, Layek B, Singh J. A Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer's Disease. Mol Pharm 2021. [PMID: 34705472 DOI: 10.1021/acs.molpharmaceut.1c00611] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 26 |
Ma K, Xing S, Luan Y, Zhang C, Liu Y, Fei Y, Zhang Z, Liu Y, Chen X. Glypican 4 Regulates Aβ Internalization in Neural Stem Cells Partly via Low-Density Lipoprotein Receptor-Related Protein 1. Front Cell Neurosci 2021;15:732429. [PMID: 34552470 DOI: 10.3389/fncel.2021.732429] [Reference Citation Analysis]
|
| 27 |
Piperno A, Sciortino MT, Giusto E, Montesi M, Panseri S, Scala A. Recent Advances and Challenges in Gene Delivery Mediated by Polyester-Based Nanoparticles. Int J Nanomedicine 2021;16:5981-6002. [PMID: 34511901 DOI: 10.2147/IJN.S321329] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
